Part 11/13:
China has publicly committed to making its vaccines a global public good, emphasizing equitable access. However, questions of geopolitical influence and intellectual property rights have surfaced, as nations seek to secure vaccine supplies and establish strategic partnerships.
Challenges Beyond Development: Distribution and Public Acceptance
Even after development, vaccine distribution poses logistical challenges. Maintaining proper cold chain storage—sometimes requiring ultra-cold freezers—is crucial to preserve vaccine integrity. Manufacturing scale-up, equitable access, and overcoming vaccine hesitancy fueled by misinformation or anti-vaccine sentiments remain significant hurdles.